ASCO20 – PROSPER Trial Data – Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
Dr. Andrew Krivoshik, SVP, and Oncology Therapeutic Area Head at Astellas Pharma US discusses the overall survival findings from the Phase 3 PROSPER trial in men with non-metastatic castration-resistant prostate cancer (nmCRPC) that was published in the online “New England Journal of Medicine” (NEJM) and also presented during the 2020 American Society of Clinical Oncology (ASCO20) Annual Meeting (Abstract #5515).
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Andrew P. Krivoshik began his career in academic medicine, often balancing time in the lab with time seeing patients in the clinic. Now Senior Vice President and Oncology Therapeutic Head of Astellas Pharma US, his career is focused on pharmaceutical development to help serve more patients and make a greater impact in their care. Dr. Krivoshik has expertise in global clinical development including implementing novel and innovative clinical trial designs, is a subject matter expert and primary author of clinical protocols, investigator brochures, and regulatory submissions spanning the life cycle of clinical development, and is an invited speaker and session chair at international scientific congresses.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
